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Background: Disruptions in cerebrospinal fluid (CSF) flow during aging could
compromise protein clearance from the brain and contribute to the etiology of
Alzheimer’s Disease (AD).
Objective: To determine whether CSF flow is associated with cognitive deficit in elderly
patients (>70 years).
Methods: We studied 92 patients admitted to our geriatric unit for non-acute
reasons using phase-contrast magnetic resonance imaging (PC-MRI) to calculate their
ventricular and spinal CSF flow, and assessed their global cognitive status, memory,
executive functions, and praxis. Multivariable regressions with backward selection
(criterion p < 0.15) were performed to determine associations between cognitive
tests and ventricular and spinal CSF flow, adjusting for depression, anxiety, and
cardiovascular risk factors.
Results: The cohort comprised 71 women (77%) and 21 (33%) men, aged
84.1 ± 5.2 years (range, 73–96). Net ventricular CSF flow was 52 ± 40 µL/cc (range,
0–210), and net spinal CSF flow was 500 ± 295 µL/cc (range, 0–1420). Ventricular CSF
flow was associated with the number of BEC96 figures recognized (β = 0.18, CI, 0.02–
0.33; p = 0.025). Spinal CSF flow was associated with the WAIS Digit Span Backward
test (β = 0.06, CI, 0.01–0.12; p = 0.034), and categoric verbal fluency (β = 0.53, CI,
0.07–0.98; p = 0.024) and semantic verbal fluency (β = 0.55, CI, 0.07–1.02; p = 0.024).
Conclusion: Patients with lower CSF flow had significantly worse memory, visuo-
constructive capacities, and verbal fluency. Alterations in CSF flow could contribute to
some of the cognitive deficit observed in patients with AD. Diagnosis and treatment of
CSF flow alterations in geriatric patients with neurocognitive disorders could contribute
to the prevention of their cognitive decline.
Keywords: cerebrospinal fluid, cognitive dysfunction, aged patients, dementia, magnetic resonance imaging,
phase contrast
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INTRODUCTION
The cerebrospinal fluid (CSF) is an important part of the central
nervous system, as it allows exchange of water, small molecules
and proteins between the brain parenchyma and arterial and
venous blood (Oreskovic and Klarica, 2010; Brinker et al., 2014),
by either passive diffusion or active transport (Oreskovic and
Klarica, 2014; Oreskovic et al., 2017b). The CSF therefore plays an
important role in regulating brain homeostasis, waste clearance
(Puy et al., 2016), as well as intracranial pressure and blood
supply (Baledent et al., 2004). During aging, CSF turnover
can be disrupted (Rubenstein, 1998; Stoquart-ElSankari et al.,
2007) which could contribute to the etiology of age-related
neurocognitive disorders (Rubenstein, 1998; Weller et al., 2000;
Launer, 2002; Silverberg et al., 2003; Chakravarty, 2004). Several
studies revealed that patients with Alzheimer’s disease (AD) have
disrupted CSF pressure (Silverberg et al., 2006), turnover (Henry-
Feugeas and Intracranial, 2009; Serot et al., 2012), and oscillations
(Silverberg et al., 2006; Stoquart-ElSankari et al., 2007). Moreover,
biomarkers for AD are found in the CSF, and their abundance
was shown to have predictive value for clinical progression
(Wolfsgruber et al., 2017).
The increase of intracranial pressure during the cardiac cycle
causes a flow from the blood and brain interstitial fluid to the
CSF, and a net CSF flow toward its extracerebral compartment
and venous blood (Oreskovic et al., 2017a). Since this CSF flow
is important for protein clearance from the brain (Puy et al.,
2016), it is possible that impaired CSF flow could be associated
with cognitive decline (Coblentz et al., 1973; Sohn et al., 1973;
Rubenstein, 1998). Moreover, CSF flow is linked with brain
perfusion (Egnor et al., 2002; Baledent et al., 2004), defects of
which are known causes of neurocognitive disorders in the elderly
(O’Brien and Thomas, 2015). A number of studies suggested that
the choroid plexus and the ventricular walls degenerate with the
progression of AD (Serot et al., 2000; Balusu et al., 2016; Daouk
et al., 2016), but none could determine whether disrupted CSF
flow causes cognitive decline, or whether it is a by-product of AD
or normal aging.
To the authors’ knowledge, there are no published studies
that investigated the relationship between CSF flow alterations
and cognitive deficit in the elderly, adjusting for cardiovascular
risk factors for the development of neurocognitive disorders. The
purpose of this study was therefore to evaluate the association of
CSF flow in the brain ventricles and cervical spine with cognitive
deficit (assessed using neurocognitive tests in clinical settings) in
a cohort of elderly patients (>70 years) admitted to our geriatric
unit for non-acute reasons. The hypothesis was that reduced
CSF flow would be associated with cognitive deficit. Improved
knowledge of such associations could guide the development
of medical or surgical treatments to limit or prevent cognitive
decline in the elderly (Nakajima et al., 2018).
MATERIALS AND METHODS
We enrolled 115 consecutive patients admitted to our
geriatric unit for non-acute reasons between October 2015
and March 2018. The inclusion criterion was patients aged
over 70 years. Twenty-one patients were excluded because of
contraindications to phase-contrast magnetic resonance imaging
(PC-MRI) for analysis of brain fluid motion, and two patients
died before completing neurocognitive assessments. This left a
study cohort of 92 patients (Figure 1) who underwent PC-MRI
that enabled calculation of ventricular (aqueduct) CSF flow and
spinal (C2-C3) CSF flow.
Data Acquisition
The PC-MRI was performed using a 1.5-T machine.
Conventional morphologic image sequences were first acquired
FIGURE 1 | Flowchart of patient inclusion.
TABLE 1 | Patient demographics.
Cohort (n = 92)
mean ± SD (range)
Women 71 (77%)
Age (years) 84.1 ± 5.2 (73–96)
BMI (kg/m2) 25.2 ± 4.8 (15.6–40.0)
Depression (MADRSa/60) 7.3 ± 6.6 (0–31)
Anxiety (Goldberg/9) 2.8 ± 2.4 (0–9)
CSF flow
Ventricular (µL/ccb) 52 ± 40 (0–210)
Spinal (µL/ccb) 500 ± 295 (0–1420)
Diabetes 11 (12%)
Inflammation 40 (43%)
Hypercholesterolemia 5 (5%)
Hypertriglyceridemia 19 (21%)
Malnutrition 65 (71%)
Anemia 57 (62%)
Diagnosis
Mild cognitive impairment 41 (46%)
Vascular dementia 11 (12%)
Alzheimer’s disease 5 (6%)
Dementia with Lewy bodies 1 (1%)
Mixed dementia 32 (36%)
aMADRS, Montgomery-Asberg Depression Rating Scale; acc, cardiac cycle.
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in the sagittal and axial planes. The CSF flow acquisition planes
were then selected perpendicular to the presumed direction of
flow through the Sylvius aqueduct [representing the ventricular
flow (Jacobson et al., 1996)] and the spinal C2-C3 sub-arachnoid
spaces (representing the spinal flow). Flow images were acquired
using a velocity-encoded phase-contrast pulse sequence with
peripheral gating, as previously described (Baledent et al., 2001,
2004). Velocity sensitization was set at 10 cm/s for the ventricular
flow and 5 cm/s for the spinal flow.
Data Analysis
Phase-contrast magnetic resonance imaging data were
transferred to a Sparc 10 workstation (SUN Microsystems)
and analyzed using an in-house image processing software with
Interactive Data Language (Baledent et al., 2001). This software
automatically measures the CSF flow curve over the cardiac cycle
for a given region of interest. Cranial–caudal flows were positive
(CSF flush), whereas caudal–cranial flows were negative (CSF
fill). The difference between CSF fill and flush flows is the net
CSF flow, which reflects the volume of CSF produced (Nilsson
et al., 1994). For technical reasons, intracranial sub-arachnoid
CSF flow was not investigated.
Neurocognitive Assessment
All patients underwent a battery of neurocognitive tests that
assessed global cognitive status, memory, executive functions,
praxis, as well as depression and anxiety (Table 2). Global
cognitive efficiency was assessed by the Mini-Mental State
Examination (MMSE) (Folstein et al., 1975), standard of
Kalafat et al. (2003), following the GRECO standardization
and calibration, and the Mattis Dementia Rating scale (MDRS)
(Hersch, 1979; Gardner et al., 1981). The memory domain was
assessed using the Wechsler Adult Intelligence Scale (WAIS-
III) – Digit Span task (Iverson and Tulsky, 2003; Hill et al.,
2010) and the Grober-Buschke (GB) test (French version
of the Free and Cued Selective Reminding Test) (Buschke,
1984; Grober et al., 1988; Grober and Kawas, 1997; Van der
Linden and Juillerat, 2004). Instrumental cognition was assessed
with Signoret’s Battery of Cognitive Efficacy (BEC 96) (visuo-
constructive subscale) (Jacus et al., 2001). Attention and executive
domains were assessed using the Stroop Color and Words Test
(Comalli et al., 1962), as well as two categoric and semantic
verbal fluency tests, as impaired semantic fluency is a predictor
of progression to AD (Vaughan et al., 2018) and categoric fluency
may be impaired in amnesic MCI (Balthazar et al., 2007). In
addition, the patients were evaluated with the Montgomery-
Asberg Depression rating scale (MADRS) (Montgomery and
Asberg, 1979), on 60 points, and the Goldberg anxiety scale
(Goldberg et al., 1987; Huber et al., 1999) on 9 points, to rule out
effects of depression or anxiety on cognitive test results.
Mild cognitive impairment was diagnosed based on the
criteria of Petersen et al. (Petersen et al., 2001), while AD and
AD-like diseases were diagnosed according to the Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition (DSM-IV)
and the recommendations of the National Institute on Aging –
Alzheimer’s Association workgroups (McKhann et al., 2011).
TABLE 2 | Cognitive assessment.
Cohort (n = 92)
mean ± SD (range)
General Cognition
Mini Mental-State Exam (MMSE) 22.0 ± 4.8 (7–30)
Mattis Dementia Rating Scale
(MDRS)
117.7 ± 17.8 (60–143)
Memory Domain
Wechsler Adult Intelligence Scale -
(WAIS) Digit Span task
Forward (numbers) 4.4 ± 0.9 (3–7)
Backward (numbers) 2.9 ± 0.8 (2–6)
Grober-Bushke Free and Cued
Selective Reminding Test
Encoding (words) 13.8 ± 2.9 (3–16)
Recall (words) 13.8 ± 9.5 (0–36)
Storage (words) 32.8 ± 14.9 (0–48)
Intrumental Cognition Domain
BEC96 visuo-constructive subscale
(Figures)
8.5 ± 2.9 (0–12)
Executive Domain
Stroop Color and Word Test
Colors (delay, s) 23.4 ± 12.8 (6–70)
Colors (non-corrected mistakes) 0.3 ± 1.0 (0–6)
Words (delay, s) 42.1 ± 25.4 (14–147)
Words (non-corrected mistakes) 1.1 ± 2.1 (0–9)
Interference (delay, s) 55.9 ± 24.5 (15–116)
Interference (non-corrected
mistakes)
8.3 ± 7.9 (0–24)
Verbal Fluency Test
Semantics (words) 9.3 ± 6.5 (0.0–34.0)
Categories (words) 12.8 ± 6.6 (1.0–33.0)
Vascular risk factors were diagnosed based on a
comprehensive geriatric assessment performed at our geriatric
unit. Blood samples were obtained after a minimum of 10 h
of fasting. The diagnosis of diabetes was attributed with blood
glucose levels above 7 mmol/L, anemia with hemoglobin levels
below 12 (women) or 13 (men) g/dL and inflammation with
CRP levels above 10 mg/L. Likewise, the reference range was
4.1–6.5 mmol/L for total cholesterol, 0.6–1.8 mmol/L for
triglycerides and 35–50 g/L for Albumin. Malnutrition was
defined by Albumin levels<35 g/L.
Statistical Analysis
Descriptive statistics were used to summarize the data.
Shapiro–Wilk tests were used to assess the normality of
distributions. Pearson’s or Spearman’s coefficients were
calculated to identify significant correlations between CSF
flow (ventricular and spinal) and all cognitive test results.
The ventricular CSF flow was correlated with the BEC96
visuo-constructive subscale (r = 0.231, p = 0.037), while the
spinal CSF flow was correlated with the backward WAIS
digit span task (r = 0.251, p = 0.023) and the GB recall
test (r = 0.230, p = 0.054). Multivariable regressions with
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backward selection (criterion p < 0.15) were performed
to determine associations between the aforementioned
cognitive tests and thirteen independent variables, to adjust
for depression, anxiety, and cardiovascular risk factors (Barnes
and Yaffe, 2011) [gender, age, BMI, CSF flow (ventricular),
CSF flow (spinal), MADRS, and Goldberg scores, as well as
presence of diabetes, inflammation, hypercholesterolemia,
hypertriglyceridemia, malnutrition or anemia]. Statistical
analyses were performed using R version 3.3.2 (R Foundation
for Statistical Computing, Vienna, Austria). P-values <0.05 were
considered statistically significant.
RESULTS
The final cohort comprised 71 women (77%) and 21 (33%) men,
aged 84.1 ± 5.2 years (range, 73–96), with BMI 25.2 ± 4.8 kg/m2
(range, 15.6–40.0) (Table 1). The MADRS score was 7.3 ± 6.6
(range, 0–31), and 4 patients (4.3%) had scores >20, indicating
moderate to severe depression. The Goldberg score was 2.8 ± 2.4
(range, 0–9), and 23 patients (25%) had scores ≥5, indicating
possible anxiety. Net ventricular CSF flow was calculated at
52 ± 40 µL/cc (range, 0–210), and net spinal CSF flow at
500 ± 295 µL/cc (range, 0–1420). The majority of patients
reported cognitive impairment and overall diagnosis revealed
mild cognitive impairment in 41 patients (46%), vascular
dementia in 11 (12%), AD in 5 (6%), Lewy-body dementia
in 1 (1%), and mixed dementia in 32 (36%). The cognitive
assessment echoed these findings with an MMSE score of
22 ± 4.8 (range, 7–30), and a MDRS or 117.7 ± 17.8 (range,
60–143) (Table 2).
Multivariable analysis of factors affecting the memory domain
revealed that (i) the WAIS Digit Span Backward results improved
with increasing spinal CSF flow (β = 0.06, CI, 0.01–0.12;
p = 0.034) and were worse for patients with anemia (β = −0.54,
CI, −0.90 to −0.18; p = 0.004); (ii) the GB recall results increased
with spinal CSF flow (β = 0.70, CI, −0.01–1.14; p = 0.054) and
were worse in patients with malnutrition (β = −6.30, CI, −10.88
to −1.73; p = 0.008) (Table 3).
Multivariable analysis also revealed that (i) the number of
BEC96 figures recognized increased with ventricular CSF flow
(β = 0.18, CI, 0.02–0.33; p = 0.025) and decreased in patients
with malnutrition (β = −1.48, CI, −2.81 to −0.15; p = 0.029)
(Table 4); (ii) categoric verbal fluency increased with spinal CSF
flow (β = 0.53, CI, 0.07–0.98; p = 0.024) and in men (β = 3.88, CI,
0.68–7.08; p = 0.018), and was decreased in patients with diabetes
(β = −7.48, CI, −11.92 to −3.05; p = 0.001); (iii) semantic verbal
fluency increased with spinal CSF flow (×100) (β = 0.55, CI,
0.07–1.02; p = 0.024) and was decreased in patients with diabetes
(β = −5.08, CI, −9.66 to −0.51; p = 0.030).
DISCUSSION
The main finding of this study is that CSF flow was associated
with cognitive test results. Ventricular CSF flow was associated
with the number of recognized BEC 96 figures, while spinal CSF
flow was associated with the WAIS digit-span backward test,
categoric and semantic verbal fluencies, as well as the Grober-
Buschke recall test (borderline). Taken together, these results
suggest that CSF flow influences memory, visuo-constructive
capacities, and verbal fluency. Interestingly, our findings are
coherent with CSF flow values reported in recent literature. Our
measures of ventricular CSF flow were comparable to values
reported for healthy adults, but higher than those reported for
healthy elderly volunteers, while our measures of spinal CSF
flow were slightly higher than those reported for all elderly
patients, except those with amnesic mild cognitive impairment
(Table 5; Baledent et al., 2004; El Sankari et al., 2011; Puy et al.,
2016).
It is unclear how CSF flow alterations could affect cognition.
While CSF flow could be influenced by blood perfusion
TABLE 3 | Multi-variable regressions to identify factors associated with the memory domain (Backward selection p < 0.15).
WAIS Digit Span Backwards (n = 80) GB recall (n = 70)
regression coefficient 95% C.I. (range) p-value regression coefficient 95% C.I. (range) p-value
Male Gender
Age (years)
BMI (kg/m2)
CSF Flow (Ventriculara)
CSF Flow (Spinalb) 0.06 (0.01– 0.12) 0.034 0.70 (−0.01–1.41) 0.054
Depression (MADRS) −0.02 (−0.04– 0.01) 0.162
Anxiety (Goldberg)
Diabetes
Inflammation
Hypercholesterolemia −6.01 (–15.39– 3.36) 0.205
Hypertriglicerydemia
Malnutrition −6.30 (−10.88 to −1.73) 0.008
Anemia −0.54 (−0.90 to −0.18) 0.004
aregression coefficients given for increments of 10 µL/cc. bregression coefficients given for increments of 100 µL/cc.
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TABLE 4 | Multi-variable regressions to identify factors associated cognitive tests (Backward selection p < 0.15).
BEC96 Figures (n = 78) Verbal fluency (categoric) (n = 76) Verbal fluency (semantic) (n = 76)
regression
coefficient
95% C.I. (range) p-value regression
coefficient
95% C.I. (range) p-value regression
coefficient
95% C.I. (range) p-value
Male Gender 3.88 (0.68–7.08) 0.018
Age
BMI
CSF Flow (Ventriculara) 0.18 (0.02–0.33) 0.025
CSF Flow (Spinala) 0.53 (0.07–0.98) 0.024 0.55 (0.07– 1.02) 0.024
Depression (MADRS)
Anxiety (Goldberg)
Diabetes −7.48 (−11.92 to −3.05) 0.001 −5.08 (-9.66 to −0.51) 0.030
Inflammation
Hypercholesterolemia
Hypertriglicerydemia
Malnutrition −1.48 (−2.81 to −0.15) 0.029 −2.58 (−5.43–0.27) 0.076
Anemia
aregression coefficients given for increments of 10 µL/cc. bregression coefficients given for increments of 100 µL/cc.
TABLE 5 | CSF flow measures in our cohort and reported in the recent literature.
Author Date Journal Cohort n Ventricular CSF Flow (µL/cc) Spinal CSF Flow (µL/cc)
(year) mean ± SD mean ± SD
This study – – Hospitalized elderly 92 52 ± 40 500 ± 295
Puy et al. 2016 Frontiers in Aging Neuroscience CH patients 9 174 ± 174 444 ± 188
El Sankari et al. 2011 Fluids and Barriers of the CNS Healthy elderly 12 34 ± 17 457 ± 154
El Sankari et al. 2011 Fluids and Barriers of the CNS aMCI patients 10 73 ± 33 584 ± 152
El Sankari et al. 2011 Fluids and Barriers of the CNS AD patients 9 39 ± 18 450 ± 221
El Sankari et al. 2011 Fluids and Barriers of the CNS NPH patients 13 167 ± 89 455 ± 221
Balédent et al. 2004 Investigative Radiology Healthy adults 16 51 ± 25 467 ± 147
Balédent et al. 2004 Investigative Radiology CH patients 12 196 ± 100 467 ± 260
cc, Cardiac Cycle; CH, Communicating Hydrocephalus; aMCI, amnesic mild cognitive impairment; AD, Alzheimer’s disease; NPH, normal-pressure hydrocephalus.
(Baledent et al., 2004), the cognitive picture of altered CSF
flow offered in this study is more reminiscent of AD
(Chakravarty, 2004) rather than vascular dementias, in which
memory deficits are less constant (O’Brien and Thomas,
2015). Impaired CSF flow was shown to affect the local
biochemical composition of CSF (Puy et al., 2016), and
thus, could affect protein clearance. This could lead to
amyloid or phosphorylated tau accumulation in the brain
parenchyma, which are thought to be important elements in
the etiology of AD, and whose concentration in the CSF was
shown to predict clinical development (Wolfsgruber et al.,
2017). This is consistent with ongoing research into CSF
biology suggesting that CSF and interstitial fluid exchange
along a brain-wide perivascular network, linking glial and
vascular function (Simon and Iliff, 2016). This “glymphatic
system” is hypothesized to contribute to neuroinflammation
and neurodegeneration, especially in the aging brain. CSF
flow disruptions are common in AD (Silverberg et al.,
2006; Stoquart-ElSankari et al., 2007; Henry-Feugeas and
Intracranial, 2009; Serot et al., 2012), confirming an etiological
role for CSF flow disturbance in the development of late-
onset AD.
Normal pressure hydrocephalus (NPH) is a rare form of
neurocognitive disorder, in the elderly – characterized by the
triad of dementia, gait apraxia and incontinence – thought to
be caused by impaired CSF circulation (Leinonen et al., 2017).
Its effects on cognition are similar to AD, and several studies
(Del Bigio et al., 1997; Bech et al., 1999; Savolainen et al., 1999;
Silverberg et al., 2006) underlined the high prevalence of AD
in patients meeting clinical criteria for hydrocephalus. Results
of hydrocephalus treatment by ventriculoperitoneal shunting are
promising (Silverberg et al., 2002; Nakajima et al., 2018), but a
trial to apply this technique in AD patients showed no benefits
(Silverberg et al., 2008). Thus, it is likely that AD and NPH are
separate disorders, with some clinical similarity. However, due
to its rarity and to partial overlap of symptoms, NPH is often
misdiagnosed as AD. Unlike in AD, where ventricular CSF flow is
normal or decreased (Silverberg et al., 2006), in NPH, ventricular
CSF flow is increased (El Sankari et al., 2011). Measurement
of CSF flow as performed in this study thus presents the
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opportunity to better diagnose neurocognitive disorders of the
elderly and offer appropriate treatment. Further, a proportion
of AD patients is characterized by symptoms resembling NPH
(Silverberg et al., 2002; Chakravarty, 2004), and in light of our
findings, it is likely that CSF flow impairment is responsible for
some cognitive impairment in these patients, who could therefore
benefit from treatment (Attier-Zmudka et al., 2016).
In this study, multivariable analysis revealed negative
associations between diabetes and executive functions (as
indicated by the verbal fluency tests), between malnutrition and
episodic memory and executive function (indicated by the GB
recall test and the categoric verbal fluency test, respectively),
and between anemia and working memory (indicated by the
WAIS digit span backward test). In addition, men had greater
categoric fluency, which could be explained by the fact that
they were on average younger than the women (80 ± 4.8 vs.
85 ± 4.9 years, respectively). Our findings are consistent with
the literature: Diabetes is an important predictor of cognitive
decline in the elderly and is associated with deficits in attention
and executive functions (Ryan et al., 2016). Malnutrition is
a broad disorder, but folate levels have been associated with
reduced episodic memory (Hassing et al., 1999). Similarly, low
hemoglobin levels are known to affect memory in the elderly
(Shah et al., 2009).
This study is the first to report direct associations between CSF
flow and cognition, and could improve our understanding of the
complex etiologies and symptoms of neurocognitive disorders
in the elderly. It shows that altered CSF flow is associated
with cognitive deficits in elderly patients, and thus suggests
that treatments aiming at restoring normal CSF flow could
reduce cognitive deficits. This is in accordance with a clinical
observation in our practice, of a patient who recovered from
debilitating neurocognitive disorders after sleep apnea treatment
and ventriculoperitoneal shunting (Attier-Zmudka et al., 2016).
However, this study has certain limitations. First, hydrocephalus
diagnosis could not be performed in these patients, though
it was suspected in several cases. Advanced hydrocephalus
presents a complex etiological picture, and the presence of
these patients in our cohort could affect the results of the
study. Second, patients with more severe cognitive deficit had
difficulty in performing the tests, and could not provide data,
so that the multivariable models do not make use of the full
cohort. Third, the scope of the study is limited by the lack
of control group of age-matched patients with no cognitive
impairment, so we cannot extrapolate our findings to the general
population. Finally, our list of competing risk factors was
incomplete, and we were unable to correctly or systematically
assess the patients’ smoking habits, alcohol consumption, or lack
of physical activity.
In conclusion, this study revealed direct associations of
ventricular and spinal CSF flows with cognitive scores in a
geriatric population with cognitive impairment. CSF flow was
associated with memory, visuo-constructive ability and verbal
fluency. It is therefore possible that CSF flow alterations are
responsible for at least a part of the cognitive deficit observed
in our patients. Better diagnosis and treatment of CSF flow
alterations in geriatric patients suffering from neurocognitive
disorders is therefore recommended.
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